课题基金 / 基金详情

The Role of Anaphylatoxins, C3a, C5a, in Renal Injury.

The Role of Anaphylatoxins, C3a, C5a, in Renal Injury.
过敏毒素、C3a、C5a 在肾损伤中的作用。
批准号:
11671033
负责人:
MATSUO Seiichi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MATSUO Seiichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The following new findings were obtained by this research project.(A) The anaphylatoxin C5a plays an important role in glomerular thrombosis, which is one of the characteristic features of complement mediated severe glomerular injury.(B) A peptide, which specifically blocks C5a-receptor, effectively inhibits glomerular thrombosis in a rat model of experimental glomerulonephritis.(C) Recombinant human soluble thrombomodulin (RHS-TM) completely inhibits the glomerular thrombosis in this model, and this effect is partly mediated through the activation of proCPR (or TAFI) by TM-thrombin complex. Potato carboxypeptidase inhibitor (PCI), a specific inhbitor of CPR, ameliorated the antiinflammatory action of RHS-TM.Activated proCPR forms CPR and inactivates anaphylatoxins by removing the terminal arginine residues.(D) Anaphylatoxin receptors are expressed in the kidney and they are upregulated in human glomerulonephritis such as lupus nephritis.These results suggest that anaphylatoxins are the important byproducts during complement activation cascade which play important roles in the development of glomerular injury. Recently our group has cloned rat CPR.Since rat is the important animal which provides us a variety of renal injury models, we will be able to test the hypothesis by using recombinant CPR or CPR gene transfer that the control of anaphylatoxins will lessen the complement-mediated renal injury in vivo.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
Mizuno M,Nishikawa K,Okada N,Matso S,Ito K,Okada H: "Inhibition of a membrane complement regulatory protein by a monocional antibody induces acute lethal shock in rats promed with lipoplysaccharide."Journal of Immunology. 162. 5477-5482 (1999)
Mizuno M、Nishikawa K、Okada N、Matso S、Ito K、Okada H:“单克隆抗体抑制膜补体调节蛋白会在脂多糖刺激的大鼠中诱导急性致死性休克。”免疫学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Watanabe M,Morita Y,Mizuno M,Nishikawa K,Matsuo S,et al.: "CD59 protects kidneys from complement mediated innjury in collaboration with Crry in rats."Kidney International. 58. 1569-1579 (2000)
Watanabe M、Morita Y、Mizuno M、Nishikawa K、Matsuo S 等人:“CD59 与 Crry 合作,在大鼠中保护肾脏免受补体介导的损伤。”肾脏国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Watanabe M, Morita Y, Mizuno M, Nishikawa K, Yuzawa Y, Hotta N, Morgan BP, Okada N, Okada N, Matsuo S: "CD59 protects kidneys from complement mediated innjury in collaboration with Crry in rats."Kidney International. 58. 1569-1579 (2000)
Watanabe M、Morita Y、Mizuno M、Nishikawa K、Yuzawa Y、Hotta N、Morgan BP、Okada N、Okada N、Matsuo S:“CD59 与 Crry 合作,在大鼠中保护肾脏免受补体介导的损伤。”肾脏国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wakai K,Kawamura T,Matsuo S,Hotta N,Ohno Y: "Risk factor for IgA nephropathy : a case-control study in Japan."American Journal of Kidney Diseases. 33. 738-745 (1999)
Wakai K、Kawamura T、Matsuo S、Hotta N、Ohno Y:“IgA 肾病的危险因素:日本的病例对照研究。”美国肾脏病杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Development of novel therapy for kidney injury by leukocyte targeting antibody-fused Bionanocapsules
    • 批准号:
      25670408
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MATSUO Seiichi
    • 依托单位:
    Elucidation of molecular mechanisms involved in the immunomodulatory function of newly developed adipose tissue derived mesenchymal stem cells
    • 批准号:
      23659443
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      MATSUO Seiichi
    • 依托单位:
    International comparison of genomic variations for prognostic factors in chronic kidney disease
    • 批准号:
      23406027
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2011
    • 负责人:
      MATSUO Seiichi
    • 依托单位:
    Epidemiological analysis on chronic kidney disease in Asian population after standardization of creatinine measurement
    • 批准号:
      20406022
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2008
    • 负责人:
      MATSUO Seiichi
    • 依托单位:
    海外基金